bf/NASDAQ:BIIB_icon.jpeg

NASDAQ:BIIB

Biogen Inc.

  • Stock

120.93

−0.12%

−11.66

USD last updated 25/07 01:50:18

Last Close

132.59

24/07 21:09

Market Cap

33.89B

Beta: 0.19

Volume Today

2.32M

Avg: 876.67K

PE Ratio

24.00

PFCF: 34.22

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing EN...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    2468102017-07-252019-07-232021-07-222023-07-252024-10-30

    Revenue (Estimate*)

    1B2B3B4B2017-07-252019-07-232021-07-222023-07-252024-10-30

    *Estimate based on analyst consensus